Jonathan Lenzen
Critical Care Medicine · Jasper, TNNPI 1275502510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AstraZeneca at 36.8% of the total. 2023 is the largest year on record at $689, 2.7 times the $252 reported in 2019.
Across 107 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$832
- GSK$358
- Sunovion Pharmaceuticals Inc.$249
- Grifols USA, LLC$221
- Takeda Pharmaceuticals U.S.A., Inc.$173
- Boehringer Ingelheim$75
- plus $354 from 11 others
What the payments were for
- Food & beverage$2,21198%
- Education$512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $832 |
| GSK | 19 | $358 |
| Sunovion Pharmaceuticals Inc. | 18 | $249 |
| Grifols USA, LLC | 4 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $173 |
| Boehringer Ingelheim | 3 | $75 |
| Mallinckrodt Hospital Products Inc. | 3 | $61 |
| ANI Pharmaceuticals, Inc. | 2 | $47 |
| Mylan Specialty L.p. | 3 | $42 |
| Insmed, Inc. | 2 | $41 |
| Baxter Healthcare | 2 | $40 |
| Pfizer | 1 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| ADMA Biomanufacturing LLC | 1 | $20 |
| Bayer | 1 | $18 |
| Philips North America LLC | 1 | $16 |
| Vapotherm Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolastin-C Liquid$162
- BREZTRI$116
How this compares
$2,262 in reported general payments places this provider in the 75th percentile of 141 critical care medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 12 | $158,821 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $21,701 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $1,178 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev | $75 | $158,82112 claims |
| GSKTrelegy Ellipta | $358 | $21,70132 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 141 critical care medicine providers in Tennessee.
Other critical care medicine in Jasper
- Gordon BernardNashville$730K
- Todd RiceNashville$291K
- Jeffery NelsonMaryville$147K
- Jeremy GreenbergChattanooga$64K
- Anthony MattoxMemphis$33K
- Jamie DeneauNashville$33K
- Ann GageNashville$22K
- Nathan WildsMemphis$19K
- Lora Cooper-YoakumKnoxville$18K
- Lorraine WareNashville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.